Entyvio (vedolizumab) is used in adults for the treatment of moderate to severe Ulcerative Colitis or Crohn’s Disease.
Entyio works by preventing an excess of white blood cells from entering the GI tract. This helps to control inflammation and symptoms of ulcerative colitis and Crohn’s disease.
Entyvio is administered intravenously over a period of about 30 minutes. An observation time may be required after the infusion. Entyvio is usually given every 8 weeks. Infusions may be given more frequently at the start of therapy, known as the induction period.
Potential Side Effects
The most common side effects of Entyvio include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, and pain in extremities.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Entyvio website.
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices, Patient Rights and Responsibilities, and Appointment Lateness and Cancelation are for reference only. Please contact us if you have any questions!
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP